$2.3T
Total marketcap
$105.09B
Total volume
BTC 49.76%     ETH 15.58%
Dominance

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 2TZ.SG Stock

1.86 EUR {{ price }} 1.292777% {{change_pct}}%
COUNTRY
Germany
Exchange
Stuttgart
Market Cap
2.7B EUR
LOW - HIGH [24H]
1.86 - 1.86 EUR
VOLUME [24H]
0 EUR
{{ volume }}
P/E Ratio
11.65
Earnings per share
0.16 EUR

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Price Chart

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 2TZ.SG Financial and Trading Overview

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited stock price 1.86 EUR
Previous Close 1.89 EUR
Open 1.91 EUR
Bid 1.97 EUR x 5000000
Ask 2.04 EUR x 5000000
Day's Range 1.91 - 1.91 EUR
52 Week Range 0.89 - 2.14 EUR
Volume 0 EUR
Avg. Volume 0 EUR
Market Cap 3.78B EUR
Beta (5Y Monthly) 0.972413
PE Ratio (TTM) 10.588888
EPS (TTM) 0.16 EUR
Forward Dividend & Yield 0.15 (7.57%)
Ex-Dividend Date May 26, 2023
1y Target Est N/A

2TZ.SG Valuation Measures

Enterprise Value -1388390016 EUR
Trailing P/E 10.588888
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.44376534
Price/Book (mrq) 0.21348566
Enterprise Value/Revenue -0.163
Enterprise Value/EBITDA -1.466

Trading Information

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock Price History

Beta (5Y Monthly) 0.972413
52-Week Change 84.09%
S&P500 52-Week Change 20.43%
52 Week High 2.14 EUR
52 Week Low 0.89 EUR
50-Day Moving Average 1.88 EUR
200-Day Moving Average 1.24 EUR

2TZ.SG Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 200M
Float 426.62M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0.059%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.12
Trailing Annual Dividend Yield 59.19%
5 Year Average Dividend Yield 478.00%
Payout Ratio 0.3652
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 12.48%
Operating Margin (ttm) 9.80%
Gross Margin 41.85%
EBITDA Margin 11.12%

Management Effectiveness

Return on Assets (ttm) 5.17%
Return on Equity (ttm) 15.67%

Income Statement

Revenue (ttm) 8.51B EUR
Revenue Per Share (ttm) 11.05 EUR
Quarterly Revenue Growth (yoy) 14.00%
Gross Profit (ttm) N/A
EBITDA 947.26M EUR
Net Income Avi to Common (ttm) 1.06B EUR
Diluted EPS (ttm) 0.18
Quarterly Earnings Growth (yoy) 100.79%

Balance Sheet

Total Cash (mrq) 3.46B EUR
Total Cash Per Share (mrq) 4.47 EUR
Total Debt (mrq) 606.7M EUR
Total Debt/Equity (mrq) 8.75 EUR
Current Ratio (mrq) 2.22
Book Value Per Share (mrq) 8.928

Cash Flow Statement

Operating Cash Flow (ttm) 785.39M EUR
Levered Free Cash Flow (ttm) 679.29M EUR

Profile of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Country Germany
State N/A
City Tianjin
Address Zhong Xin Mansion
ZIP 300193
Phone 86 22 2702 0892
Website https://www.zhongxinp.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 4913

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.

Q&A For Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock

What is a current 2TZ.SG stock price?

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 2TZ.SG stock price today per share is 1.86 EUR.

How to purchase Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited stock?

You can buy 2TZ.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited?

The stock symbol or ticker of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is 2TZ.SG.

Which industry does the Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited company belong to?

The Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited industry is Drug Manufacturers-Specialty & Generic.

How many shares does Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited have in circulation?

The max supply of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited shares is 1.45B.

What is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Price to Earnings Ratio (PE Ratio)?

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited PE Ratio is 11.65500000 now.

What was Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited earnings per share over the trailing 12 months (TTM)?

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited EPS is 0.16 EUR over the trailing 12 months.

Which sector does the Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited company belong to?

The Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited sector is Healthcare.